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in renal outer medulla fractions of HC. Taken together, the 
hypothesis of impairment in TAL was excluded. Actually, the 
expression of the epithelial Mg 2+ channel in renal cortical 
membrane fractions was reduced in HC.  Conclusion: Impair-
ment in distal convoluted tubule induced by hypercholester-
olemia explains high magnesuria and hypomagnesemia ob-
served in HC.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Hypercholesterolemia is one of the major risk factors 
in the development of cardiovascular diseases including 
hypertension and ischemic damage in distinct organs. 
Currently, atherosclerosis is considered an inflammatory 
disease in which cytokines, proteases and vasoactive 
molecules are released from the endothelium due to oxi-
dative stress generated by LDL cholesterol accumulated 
in the intima  [1, 2] . Consequently, an impairment of en-
dothelium-dependent vasodilatation occurs and nonvas-
cular tissues may also be targeted by the inflammatory 
effector mechanism  [3] . Hence, hypercholesterolemia 
may induce vascular and nonvascular injuries in the or-
gans.
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 Abstract 
 Background/Aims: Hypomagnesemia may induce hyper-
cholesterolemia, but the contrary has not been described 
yet. Thus, magnesium homeostasis was evaluated in rats fed 
a cholesterol-enriched diet for 8 days. This study has a rele-
vant clinical application if hypomagnesemia, due to hyper-
cholesterolemia, is confirmed in patients with long-term hy-
percholesterolemia.  Methods: Both hypercholesterolemic 
(HC) and normocholesterolemic rats (NC) were divided into 
sets of experiments to measure hemodynamic parameters, 
physiological data, maximum capacity to dilute urine (CH2O  ), 
variations (  ) in [Ca 2+ ] i and the expression of transporter pro-
teins.  Results: HC developed hypomagnesemia and showed 
high magnesuria in the absence of hemodynamic abnormal-
ities. However, the urinary sodium excretion and C H2O in HC 
was similar to NC. On the other hand, the responses to an-
giotensin II by measuring   [Ca 2+ ] i were higher in the thick 
ascending limb of Henle’s loop (TAL) of HC than NC. More-
over, high expression of the cotransporter NKCC2 was found 
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 Previous studies conducted by our laboratory demon-
strated that hypercholesterolemia is associated with poor 
prognosis in acute renal failure  [4] , aggravates radiocon-
trast nephrotoxicity  [5] and may impair renal autoregula-
tion  [6] . In these studies, the vascular factor was probably 
the major mechanism involved in the pathophysiology of 
these findings. In another study  [7] , maternal hypercholes-
terolemia was evaluated and pregnancy abnormalities 
were observed in the absence of hypertension. Moreover, 
disturbances in the development of the offspring including 
reduction in creatinine clearance associated with high uri-
nary excretion of sodium, potassium and water in adult-
hood were also observed. Again, these observed effects 
were in the absence of hypertension. Thus, a nonvascular 
mechanism may also play a role in the development of the 
abnormalities induced by maternal hypercholesterolemia.
 Magnesium deficiency may alter metabolism of elas-
tin, proliferation of collagen, calcification, lipid metabo-
lism and platelet aggregation  [8] . Magnesium is the sec-
ond most important intracellular cation and it functions 
as a cofactor for many cellular processes which include 
the regulation of several ion channels and the activity of 
Na + ,K + -ATPase  [8, 9] . Hence, magnesium depletion may 
induce failure in the renal and cardiovascular systems 
and may induce hypercholesterolemia in humans  [9–13] . 
It has been reported that magnesium intake is inversely 
associated with the incidence of type 2 diabetes  [14] and 
the prevalence of the metabolic syndrome in older adults 
 [15] . However, studies demonstrating that hypercholes-
terolemia may induce hypomagnesemia have not been 
carried out to date.
 The aim of this study was to evaluate if hypercholes-
terolemia can induce abnormalities in electrolyte homeo-
stasis due to changes in renal tubular function. Thus, a 
short period of high cholesterol feeding was chosen to in-
duce hypercholesterolemia in rats. This protocol elicits 
cholesterol plasma without changes in blood pressure 
(BP), glomerular filtration rate (GFR) and renal blood 
flow (RBF)  [6] . Although the short period of high choles-
terol feeding may seem to be an acute effect of hypercho-
lesterolemia in renal rat function, the results will have 
clinical relevance if the hypothesis is confirmed, espe-
cially if hypomagnesemia occurs in consequence of a re-
nal tubular dysfunction. Thus, studies conducted in hu-
mans with long-term hypercholesterolemia will be re-
quired to evaluate magnesium homeostasis. It is possible 
that chronic hypercholesterolemia is in fact the cause of 
hypomagnesemia that is often observed in critically ill 
patients and which has been associated with increased 
morbidity and mortality in hospitalized patients  [12, 13] .
 Methods 
 Experimental Groups 
 Male Wistar rats, weighing   200 g, were randomly housed in 
individual cages. They were fed a standard diet or a standard diet 
supplemented with 4% (w/w) cholesterol and 1% (w/w) cholic acid 
for 8 days  [4–7] . The animals were anesthetized with sodium 
thionembutal (50 mg/kg b.w., i.p.) to perform all surgical prepara-
tions or to harvest the kidneys in the case of in vitro experiments.
 This study was conducted in accordance with the guidelines 
of the Ethics Committee of the Hospital das Clínicas da Faculdade 
de Medicina da Universidade de São Paulo.
 Renal Blood Flow 
 RBF was measured under anesthesia, as previously described 
 [6] . Briefly, catheters were placed in the trachea, external jugular 
vein for fluid infusion and in femoral artery to measure BP. A 
midline incision in abdomen was made and the left renal pedicle 
was carefully microdissected to place an ultrasonic flow probe 
(T106 Transonic Systems, Bethesda, Md., USA). RBF was record-
ed every 10 s during 10 min for each experiment and the renal 
vascular resistance (RVR) was calculated as the ratio of BP and 
RBF.
 Metabolic Cage Studies 
 Rats fed either a standard diet or a cholesterol-enriched diet 
were placed in individual metabolic cages to collect urine under 
mineral oil for 24 h. To avoid contamination in urine samples the 
diet was restricted, but they were allowed to drink water ad libi-
tum. At the end of this period, the animals were anesthetized to 
collect blood samples via a PE-200 inserted into the abdominal 
aorta.
 Urine and plasma osmolality was determined by the freezing-
point method (The Advanced Osmometer; 3D3, Mass., USA). So-
dium and potassium were measured in urine and plasma by flame 
photometry (CELM-FC280, Brazil). The enzymatic colorimetric 
method (Labtest; Minas Gerais, Brazil) was used to quantify levels 
of magnesium, calcium, phosphorus, chloride and creatinine in 
urine and plasma. In the serum, total cholesterol and aldosterone 
were also measured using enzymatic colorimetric method and 
serum by radioimmunoassay, respectively (Coat-A-Count; DPC, 
Los Angeles, Calif., USA).
 Free Water Clearance 
 Free water clearance (CH2O) was measured in another set of 
animals  [16] . Briefly, a tracheotomy was performed and two poly-
ethylene (PE-60) catheters were inserted in two external jugular 
veins for infusion of inulin and fluids. A hypotonic saline solution 
(150 mosm) was infused at a rate of 0.03 ml/min for 15 min im-
mediately after a jugular vein had been cannulated. Thereafter, a 
more hypotonic saline solution (135 mosm) was infused at differ-
ent rates (0.03, 0.06 and 0.08 ml/min) according to the diuresis 
observed  [16] . Subsequently, one PE-60 was inserted in a carotid 
artery to collect blood samples and to measure BP and one PE-240 
was placed in the bladder to collect urine samples. When the sur-
gical procedure was completed, a priming dose of inulin (100 mg/
kg b.w.) was administered by a jugular vein, followed by a constant 
inulin infusion (10 mg/kg b.w.) at a rate of 0.04 ml/min. Blood 
samples were collected at the beginning and at the end of the ex-
periment and inulin was assayed by the anthrone method in all 
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blood and urine samples  [17] . CH2O and the distal delivery of so-
dium chloride (DD NaCl ) were calculated using the following for-
mulas: 
	 
 	 

	 

	 
 	 

	 

2
2
H O
H O
NaCl
Urine volume ml/min Osmolar clearance ml/min
C 100
Inulin clearance ml/min
Sodium clearance ml/min C ml/min
DD 100
Inulin clearance ml/min
 q
 q
 Na + ,K + -ATPase Assay 
 In another series of anesthetized animals, the kidneys were 
harvested to dissect the cortex and the outer medullas at 4  °  C. The 
tissue fragments were homogenized with a Teflon pestle in a 20/1 
(v/w) cold solution (4  °  C) containing 0.25  M sucrose, 6 m M EDTA, 
20 m M imidazole, 2.4 m M sodium deoxycholate (pH 6.8), and fil-
tered through a double layer of surgical gauze. The Na + ,K + -ATPase 
activity was measured by the inorganic phosphate (P i ) released 
from ATP labeled with   [ 32 P]. The Na + ,K + -ATPase activity was 
defined as the difference of  32 P liberated in total and basal ATPase 
assays, corrected for the spontaneous nonenzymatic breakdown 
of ATP and reported as   M P i /mg protein   h –1 , as described by 
Assis et al.  [7] .
 Isolation and Calcium Signaling in Isolated Nephron 
Segments 
 After anesthesia, the medullary segments of the thick as-
cending limb of Henle’s loop (mTAL) and collecting duct 
(OMCD) were isolated from collagenase-treated kidney  [18, 19] . 
The tubules were microdissected in standard solution (composi-
tion in m M : 127 NaCl, 5 KCl, 0.8 MgSO 4 , 0.33 Na 2 HPO 4 , 
0.44 KH 2 PO 4 , 2 CaCl 2 , 1-hydroxyethylpiperazine-N  -2-ethane-
sulfonic acid (Hepes), pH 7.4, and 1 mg/ml bovine serum albu-
min) at 4  °  C under a stereomicroscope (Hund GmbH, Germany). 
The tubules were identified by morphological and topographical 
criteria. Each isolated tubule was transferred to a thin glass mi-
croscope coverslip in 1   l standard solution containing 1% aga-
rose (type IX; Sigma-Aldrich) that was fixed by cooling the slide 
for 5 min on ice. The tubules embedded in jellied agarose were 
then loaded with 10   M acetoxymethyl ester of fura 2 (fura 
2-AM; Molecular Probes, USA) for 45 min at room temperature 
in darkness.
 The glass slip with the sample was glued to the bottom of a 
superfusion chamber and fixed on the stage of an inverted fluo-
rescent microscope (Nikon, Japan) equipped with Fluor  ! 40 ob-
jective to measure intracellular calcium concentration ([Ca 2+ ] i ) by 
using a Photoscan microfluorimeter (Photon Technology Inter-
national, USA). The sample was continuously superfused with the 
standard solution (0.6 ml/min, 37   °   C) carrying or not carrying 
angiotensin II (Ang II) for 5 min. The sample was alternately ex-
cited at 340 and 380 nm (4 s/cycle), and the fluorescence emitted 
at 510 nm from an area defined by an adjustable window (about 
25  ! 30 mm) was measured. Background was routinely recorded 
for both wavelengths at the end of each experiment and subtract-
ed from all measurements.
 [Ca 2+ ] i was calculated using the equation of Grynkiewicz et al. 
 [20] :
 [Ca 2+ ] i = K d  !   (R – R min )/(R max – R)
 where K d is the dissociation constant for the fura 2-Ca 2+ complex, 
R is the ratio of fluorescence emitted for each wavelength 
(340/380), R max is the maximal ratio emitted in the presence of 
saturating free calcium, R min is the minimal ratio measured in the 
absence of free calcium, and   is the ratio of fluorescence obtained 
at 380 nm in the absence and presence of saturating free calcium. 
The values of R min , R max and   were periodically determined by 
external calibration using a buffer kit (Molecular Probes, USA) 
that mimicked the intracellular medium  [19] . 
 Specific Antibodies to Aquaporin 2 (AQP2), Na,K-2Cl 
Cotransporter (NKCC2), Renal Outer Medullary Potassium 
Channel (ROMK) and Transient Receptor Potential Channel 
Melastatin Subtype 6 (TRPM6) 
 The peptide-derived polyclonal antibody specific to TRPM6 
was kindly supplied by Dr. Vladimir Chubanov (Institute for 
Pharmacology and Toxicology, Philipps University Marburg, 
Marburg, Germany). The peptide-derived polyclonal antibodies 
specific to AQP2, ROMK and actin were obtained from Santa 
Cruz Biotechnology (Santa Cruz, Calif., USA) and the peptide-
derived polyclonal antibody specific to NKCC2 was from Milli-
pore (USA).
 Preparation of Membrane Fractions 
 Using a Teflon pestle glass homogenizer (Schmidt & Co., 
Frankfurt am Main, Germany), cortex and medulla samples 
were homogenized in an ice-cold isolation solution (200 m M 
mannitol, 80 m M Hepes and 41 m M KOH, pH 7.5) containing 
protease inhibitor cocktail (Sigma, St. Louis, Mo., USA). The ho-
mogenates were centrifuged at low speed (2,000  g ) for 15 min at 
4  °  C to remove nuclei and cell debris. The supernatants were then 
spun at 100,000  g for 1 h at 4   °   C (70 Ti rotor; Beckman Coulter, 
Inc., Fullerton, Calif., USA), producing pellets containing mem-
brane fractions enriched with plasma membranes and intracel-
lular vesicles. The pellets were suspended in the same isolation 
solution.
 Electrophoresis and Immunoblotting 
 Samples of membrane fractions were run on polyacrylamide 
minigels, 12% (for AQP2 and ROMK) or 8% (for NKCC2 and 
TRPM6). After transfer by electroelution to nitrocellulose mem-
branes (PolyScreen, PVDF Transfer; NEN Life Science, Boston, 
Mass., USA), blots were blocked with 5% milk and 0.1% Tween 20 
in phosphate-buffered saline (NaCl 8.7 g/l, dibasic phosphate 7.2 
m M and monobasic phosphate 2.8 m M ) for 1 h. Blots were then 
incubated with anti-AQP2 antibody (1: 2,000), NKCC2 antibody 
(1: 1,000), ROMK (1: 500) or TRPM6 antibody (1: 500). The labeling 
was visualized with horseradish peroxidase-conjugated second-
ary antibody (anti-rabbit IgG, diluted 1: 2,000, or anti-goat IgG, 
diluted 1: 5,000; Sigma) using an enhanced chemiluminescence 
system (Amersham Pharmacia Biotech, Piscataway, N.J., USA).
 Quantitation of Renal Protein Levels 
 The enhanced chemiluminescence films presenting bands 
within the linear range were scanned using the ImageJ (National 
Institute of Mental Health, Bethesda, Md., USA). These bands 
were normalized through evaluation of densitometric actin pro-
tein abundance. Bands corresponding to protein expression of 
AQP2, NKCC2, ROMK, and TRPM6 were expressed as percent-
ages of control.
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 Statistical Analysis 
 Data are expressed as means  8 SE. Unpaired Student’s t test 
was used for comparisons between groups and paired Student’s t 
test was used for dual comparisons on the same nephron segment 
between baseline and Ang II treatment. The Mann-Whitney test 
was used for densitometric analysis. Values of p  ! 0.05 were con-
sidered significant.
 Results 
 As expected, high cholesterol feeding for 8 days did 
not change BP, RBF or RVR ( table 1 ). In addition, the met-
abolic cage studies confirmed that high cholesterol feed-
ing for 8 days was enough to induce hypercholesterolemia 
without changes in GFR that was determined by creati-
nine clearance ( table 2 ).
 With regard to electrolyte homeostasis, all of them 
were in a normal range in the serum of hypercholesterol-
emic rats (HC) with the exception of magnesium ( table 2 ). 
It was observed that HC developed hypomagnesemia 
with a marked increase in urinary excretion of this cation 
( table 2 ). Moreover, a marked increase in urinary excre-
tion of calcium was also observed in HC ( fig. 1 ), and HC 
had a lower capacity to excrete potassium than normo-
cholesterolemic rats (NC) despite a significant increase in 
serum aldosterone ( fig. 2 ).
 Concerning renal handling of water, the urine output 
and the water intake were significantly higher in HC than 
NC. Urine osmolarity and the calculus of free water reab-
sorption corrected for either creatinine clearance or os-
molar clearance were significantly lower in HC than in 
NC ( fig. 3 ).
 Free Water Clearance 
 In another series of animals, the renal capacity to ex-
crete water was evaluated. The free water clearance 
reached the maximum in both HC and NC with similar 
distal delivery of sodium chloride ( fig. 4 ). Both HC and 
NC reduced the urinary osmolality to the same low range 
and it took them the same time to reach this maximal ef-
fect. However, differences in diluting capacity were ob-
served between HC and NC when the free water clear-
ance was correlated with the distal delivery of sodium 
chloride. As can be seen in  figure 5 , the free water clear-
ance was low when the distal delivery of sodium chloride 
was also low. On the other hand, when the distal delivery 
of sodium chloride was elicited, the magnitude of the free 
water clearance in HC was proportionally lower than in 
NC (F o = 34.96  1 F    = 4.085, p  ! 0.0001).
Table 1. B ody weight and hemodynamic measurements in HC 
and NC rats
Body
weight
g
Blood
pressure
mm Hg
Renal
blood flow
ml/min/
100 g b.w.
Renal
vascular
resistance
mm Hg/
ml/min
NC (n = 8) 229.283.8 106.285.3 3.8080.18 12.380.7
HC (n = 9) 233.886.5 108.083.2 3.9280.22 12.381.0
D ata are expressed as mean 8 SEM. There were no differ-
ences between groups.
Table 2.  Characteristics of HC and NC rats during metabolic cage 
studies
NC HC
Number of rats 8 8
Final body weight, g 23384 21485
Feed intake, g/day 24.981.8 24.180.9
Water intake, ml/day 21.483.5 35.281.5**
Serum concentrations
Na, mM 14281 14281
K, mM 4.8480.18 4.4180.26
Mg, mM 0.8280.03 0.7080.02*
Ca, mM 2.3880.04 2.4180.14
P, mM 2.7480.13 3.1180.29
Cl, mM 11481 11083
Creatinine, mg/dl 0.6480.05 0.6680.04
Osmolality, mosm/kg H2O 28683 29083
Total cholesterol, mg/dl 8887 240830**
Aldosterone, ng/dl 13.983.0 39.887.5**
Excretory rates
Urine output, ml/day 19.083.2 26.980.8*
Na excretion, mol/day 5188130 460891
K excretion, mol/day 1,2128137 708896*
Mg excretion, mol/day 5.080.7 13.782.1*
Ca excretion, mol/day 6.481.2 23.485.3*
P excretion, mol/day 420872 400846
Cl excretion, mol/day 1,2958281 1,3438292
Creatinine clearance, ml/min/
100 g b.w. 0.5480.07 0.6080.12
Osmolar clearance/creatinine
clearance, % 2.0780.25 2.0080.29
Free water reabsorption/creatinine
clearance, % 1.0180.26 0.1580.16*
Free water reabsorption/osmolar
clearance, % 42.789.0 8.6287.06**
D ata are expressed as mean 8 SEM.
* p < 0.05 vs. NC; ** p < 0.01 vs. NC.
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 Na + ,K + -ATPase Activity 
 As illustrated in  figure 6 , the Na + ,K + -ATPase activity 
in cortex and outer medulla of HC did not differ from 
that measured in NC.
 Calcium Signaling in mTAL and OMCD 
 [Ca 2+ ] i responses to 10 –7  M Ang II were tested in iso-
lated medullary nephron segments. Either mTAL or 
OMCD microdissected from NC and HC kidneys re-
sponded to Ang II ( table 3 ). However, mTAL of HC kid-
neys showed higher sensitivity to Ang II than mTAL of 
NC kidneys ( fig.  7 ). In contrast, the magnitude of re-
sponse to Ang II in OMCD of HC did not differ from NC.
 Immunoblot Using Membrane Fractions Prepared 
from Renal Cortex Samples to TRPM6 and Renal 
Medulla Samples to AQP2, NKCC2 and ROMK 
 As demonstrated in  table 4 and illustrated in  figure 8 , 
TRPM6 protein expression was significantly reduced in 
the renal cortical membrane fractions of HC than in NC. 
In addition, NKCC2 and ROMK protein expressions 
were significantly higher in renal outer medulla fractions 
in HC than in NC. With regard to AQP2, its protein ex-
pression in renal outer medulla fraction of HC did not 
differ from that measured in NC.
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 Fig. 1. Urinary excretion of magnesium ( a ) 
and calcium ( b ) in HC, n = 8, and NC rats, 
n = 8. Data are means  8 SEM. p  ! 0.01 as 
compared with NC. 
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 Fig. 2. Capacity to excrete potassium in HC, 
n = 8, and NC rats, n = 8.  a Urinary excre-
tion of potassium (U K V).  b Urinary potas-
sium/sodium ratio (U K /U Na ).  c Trans-tu-
bular potassium gradient (TTKG).  d Serum 
aldosterone. Data are means  8 SEM. p  ! 
0.01 and p  ! 0.02 as compared with NC. 
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 Fig. 4. Capacity to eliminate free water in 
HC, n = 6, and NC rats, n = 7.  a The maxi-
mal capacity to dilute urine determined by 
free water excretion corrected for inulin 
clearance (CH2O /C inulin ).  b The urinary os-
molarity (U osmolar ) reached at the maximal 
capacity to dilute urine.  c Time elapsed to 
reach the maximal capacity to dilute 
urine.  d Distal delivery of sodium chloride 
corrected for inulin clearance (DD NaCl /
C inulin ). Data are means  8 SEM. 
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 Discussion 
 This study showed that high cholesterol feeding in rats 
induced hypomagnesemia with high magnesium urinary 
losses due to a reduction in the expression of epithelial 
Mg 2+ channel in the renal cortex. Additionally, increases 
in urinary excretion of Ca 2+ and a reduction in the capac-
ity to excrete K + were also observed in HC. All these tu-
bular dysfunctions occurred in the absence of a vascular 
mechanism.
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 Fig. 5. Magnitude of the free water clearance corrected for inulin 
clearance (CH2O /C inulin ) plotted against the distal delivery of so-
dium chloride corrected for inulin clearance (DD NaCl /C inulin ) in 
HC, n = 6, and NC rats, n = 7. 
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 Fig. 7. In vitro studies using cytosolic 
[Ca 2+ ] i ] responses to 10 –7  M Ang II mea-
sured in a medullary segment of the mTAL 
( a ) and an outer medullary collecting duct 
(OMCD) ( b ) microdissected from HC and 
NC rats. Data are mean  8 SEM. p  ! 0.05 
as compared with NC. 
Table 3.  [Ca2+]i responses to 10–7 M Ang II in medullary nephron segments microdissected from kidneys of HC and NC rats
mTAL O MCD
n basal Ang II [Ca2+]i n basal Ang II [Ca2+]i
NC 7 6686 109811* 4288 7 8888 130816* 4289
HC 6 7087 13588* 65812** 7 10189 147811 4785
Dat a are expressed as mean 8 SEM.
[Ca2+]i = Variation in intracellular calcium concentration.
* p < 0.01 vs. basal; ** p < 0.05 vs. mTAL of NC and OMCD of NC and HC.
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 In agreement with our previous study, BP, GFR, RBF 
and RVR values remained within the normal range in the 
rats feeding a high cholesterol diet for 8 days  [6] . Thus, 
the results will be analyzed considering the characteris-
tics of each nephron segment transport in order to verify 
which nephron segment could be targeted by hypercho-
lesterolemia.
 The possibility that changes in the proximal tubule 
function occurred was not considered because the phos-
phorus filtered is reabsorbed in the proximal tubule and 
the urinary excretion of phosphorus was similar in HC 
and NC. Moreover, the distal delivery of sodium chloride 
measured in free water clearance experiments did not 
differ between HC and NC.
 The chances of impairment in TAL would be expected 
because HC showed high magnesium and calcium uri-
nary losses and less capacity to reabsorb and eliminate 
free water. However, urinary sodium excretion in HC was 
similar to NC.
 It is well known that a NKCC2 is expressed in the api-
cal side in TAL resulting in transcellular reabsorption of 
sodium chloride, which is the initial step for the counter-
current mechanism. For this reason, TAL is the decisive 
nephron segment to form concentrated or diluted urine 
 [21–23] . In consequence of chloride reabsorption, a lu-
men-positive voltage is generated, allowing passive para-
cellular transport of Ca 2+ and Mg 2+  [11, 21] . The protein 
kinase A, 20-hydroxyeicosatetraenoic acid and nitric ox-
ide regulate the NKCC2 by inhibiting its action  [24, 25] .
 Considering that increments in oxidized lipoproteins 
increase the arachidonic acid metabolites and activate 
phospholipase A 2  [2] , an inhibition in the NKCC2 could 
be expected.
 Actually, an increment in the expression of NKCC2 
was observed in renal medulla samples of HC that justi-
fies the similar urinary sodium excretion in HC com-
pared to NC. NKCC2 expression may be elicited due to a 
decrease in renal nitric oxide production caused by hy-
percholesterolemia. Studies by our laboratory in which 
rats were also fed a high-cholesterol diet showed benefits 
in renal function with  L -arginine supplementation, sug-
gesting decreases in nitric oxide production  [4, 5] . In a 
recent study, Kopkan et al.  [26] demonstrated that infu-
sions of cholesterol into the renal artery in rats induced 
antinatriuresis and antidiuresis. They showed that these 
effects were mediated by a decrease in nitric oxide pro-
duction which stimulated the NKCC2.
 In vitro tests measuring variations in [Ca 2+ ] i demon-
strated that HC have also shown high sensitivity to Ang 
II in mTAL. This finding may be associated with the in-
creases in the expression of NKCC2 in renal medulla 
samples of HC.
 Taken together, the hypothesis that high urinary loss-
es of divalent cation were due to impairment in TAL was 
not supported.
Table 4.  Quantitation of immunoblotting of membrane fractions 
prepared from kidney cortex and medulla samples; densitometric 
analysis of all samples from kidneys of HC and NC rats
AQP2 NKCC2 ROMK TRPM6
NC (n = 8) 100.583.0 102.483.0 10684.4 101.481.5
HC (n = 8) 98.085.5 138.184.4** 12888.1* 66.683.1**
D ata are expressed as mean 8 SEM.
* p < 0.05 vs. NC; ** p < 0.001 vs. NC.
50 kDa
35 kDa
29 kDa
160 kDa
40 kDa
250 kDa
Actin
Actin
Actin
Actin
NC HC
NC HC
NC HC
NC HC
a
b
c
d
 Fig. 8. Immunoblotting of membrane fractions prepared from 
kidney cortex and medulla samples: AQP2 ( a ), NKCC2 ( b ), ROMK 
( c ), and TRPM6 ( d ). 
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 The distal nephron segment was also evaluated and the 
expression of TRPM6 was measured. This divalent cation-
permeable channel is located at the luminal side of the dis-
tal convoluted tubule and is responsible for the influx of 
Mg 2+ across the luminal membrane  [11] . A reduced expres-
sion of TRPM6 in renal cortical of HC was observed, which 
explains high losses of Mg 2+ in urine and the development 
of hypomagnesemia. Expression of other transporter pro-
teins, such as TRV5 that is responsible for calcium reab-
sorption in distal convoluted tubule, may be also reduced. 
In addition, the free water clearance results also suggest 
impairment in distal convoluted tubule. Both HC and NC 
reached the maximum capacity to dilute urine. However, 
when the delivery of NaCl elicited, the free water clearance 
in HC was proportionally lower than in NC. The urinary 
diluting mechanism requires a generation of hypotonic 
fluid to reach the collecting duct. Thus, reduction in the 
ionic transport capacity in distal convoluted tubule may 
prevent a less hypotonic fluid from reaching the collecting 
duct in conditions of maximum free water diuresis.
 With regard to the collecting duct, the [Ca 2+ ] i respons-
es to Ang II and the expression of AQP2 did not differ 
between HC and NC, suggesting that high-cholesterol 
feeding did not induce abnormalities in this nephron seg-
ment. However, a reduction in the capacity to excrete K + 
was observed in HC.
 It is well established that collecting duct cells are re-
sponsible for K + secretion which is coupled with Na + re-
absorption  [27] . The Na + ,K + -ATPase present in basal 
membrane releases the energy, allowing sodium reab-
sorption through the amiloride-sensitive epithelial Na + 
channel (ENaC). A lumen-negative voltage is generated, 
favoring the secretion of K + through ROMK channels. 
Aldosterone plays an important role by increasing the ac-
tivity of Na + ,K + -ATPase and ENaC function which favors 
K + secretion  [27] .
 In this study, a significant increment in serum aldoste-
rone was observed in HC. The possibility of the activation 
of the renin-angiotensin system was thought, but it was not 
justified. The plasma chloride levels and the urinary excre-
tion of chloride in HC were within the normal range, sug-
gesting euvolemia in these animals. Moreover, Andrade et 
al.  [5] , using the same protocol to induce hypercholesterol-
emia, demonstrated that changes in volume status do not 
occur in HC. Thus, a possible explanation for high aldo-
sterone serum levels may be attributed to the need to main-
tain potassium homeostasis. In chronic renal failure, high 
levels of aldosterone are present even in the presence of 
expanded extracellular volume  [28, 29] . In recent reviews, 
Arroyo et al.  [30] and Hoorn et al.  [31] described the aldo-
sterone paradox in which aldosterone plays a role in regu-
lating K + in collecting duct cells in the absence of Ang II 
action. In this situation, aldosterone is required to main-
tain K + homeostasis and hypovolemia is not present. The 
mechanism is not totally known, but interactions of aldo-
sterone and several serine/threonine kinases, especially 
WNK4, with ion transport proteins have been suggested, 
like activation of ROMK and ENaC channels.
 In this study, the expression of ROMK was increased 
in HC, but the capacity to excrete K + was reduced and the 
Na + ,K + -ATPase activity did not increase in HC in the 
presence of high aldosterone serum levels.
 The Na + ,K + -ATPase activity in HC was twofold higher 
in homogenates from the outer medulla than from the 
cortex, which is considered within the normal range  [7, 32, 
33] . It is possible that Mg 2+ deficiency could be responsible 
for the absence of increments in the Na + ,K + -ATPase activ-
ity in HC. We may hypothesize that a difficulty to main-
tain K + homeostasis may take a place, which resulted in an 
increment in aldosterone secretion that elicited the ex-
pression of ROMK by a stimulation of WNK4.
 In conclusion, hypercholesterolemia induced tubular 
dysfunctions in the absence of hemodynamic abnormal-
ities like high magnesuria due to a reduction in the ex-
pression of TRPM6 in the renal cortex, allowing the de-
velopment of hypomagnesemia. Considering that hypo-
magnesemia is a risk factor to increase mortality rate, the 
control of the plasma Mg 2+ concentration in HC patients 
is justified and required.
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